MedPath

Effect of Intravenous Fluid Supplementation on Serum Bilirubin and Cardiorespiratory Parameters in Preterm Infants During Phototherapy

Early Phase 1
Completed
Conditions
Hyperbilirubinemia
Registration Number
NCT01550627
Lead Sponsor
University of Jena
Brief Summary

The aim of the study was to evaluate the influence of a systematic extra intravenous fluid supplementation during phototherapy in comparison to a fluid supplementation due to short term demand in preterm infants.

Detailed Description

60 preterm infants (GA ≤ 32 week) were assigned randomly to either receive a fluid supplementation due to short term demand (control group, n=30;) or a 20% extra fluid supplementation (study group, n=30) during intermediate phototherapy.

Collected data:

* cardiorespiratory parameters(heart rate, blood pressure, SaO2 and capillary refill time, breathing rate, temperature) and a pain score was completed at the first day of phototherapy

* The maximum total serum bilirubin levels (TSB) within one week after onset of phototherapy

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Hyperbilirubinemia
Exclusion Criteria
  • Preterm infants > 33 weeks of gestation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The maximum total serum bilirubin levelswithin one week after onset of phototherapy

The maximum total serum bilirubin levels within on week after onset of phototherapy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital of Jena

🇩🇪

Jena, Germany

University Hospital of Jena
🇩🇪Jena, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.